Aethlon Medical Stock Buy Hold or Sell Recommendation
| AEMD Stock | USD 1.18 0.07 5.60% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Aethlon Medical is 'Strong Sell'. Macroaxis provides Aethlon Medical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AEMD positions. The advice algorithm takes into account all of Aethlon Medical's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Aethlon Medical's buy or sell advice are summarized below:
Real Value 1.11 | Target Price 65 | Hype Value 1.18 | Market Value 1.18 | Naive Value 1.18 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Aethlon Medical given historical horizon and risk tolerance towards Aethlon Medical. When Macroaxis issues a 'buy' or 'sell' recommendation for Aethlon Medical, the advice is generated through an automated system that utilizes algorithms and statistical models.
Aethlon |
Execute Aethlon Medical Buy or Sell Advice
The Aethlon recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aethlon Medical. Macroaxis does not own or have any residual interests in Aethlon Medical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aethlon Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Aethlon Medical Trading Alerts and Improvement Suggestions
| Aethlon Medical generated a negative expected return over the last 90 days | |
| Aethlon Medical may become a speculative penny stock | |
| Aethlon Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 574.25 K. Net Loss for the year was (12.03 M) with profit before overhead, payroll, taxes, and interest of 574.25 K. | |
| Aethlon Medical currently holds about 14.92 M in cash with (10.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65. | |
| Latest headline from benzinga.com: Whats Going On With Medical Therapeutic Firm Aethlon Medical On Friday |
Aethlon Medical Returns Distribution Density
The distribution of Aethlon Medical's historical returns is an attempt to chart the uncertainty of Aethlon Medical's future price movements. The chart of the probability distribution of Aethlon Medical daily returns describes the distribution of returns around its average expected value. We use Aethlon Medical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aethlon Medical returns is essential to provide solid investment advice for Aethlon Medical.
| Mean Return | -0.58 | Value At Risk | -5.2 | Potential Upside | 3.01 | Standard Deviation | 2.66 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aethlon Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aethlon Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Aethlon Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aethlon Medical backward and forwards among themselves. Aethlon Medical's institutional investor refers to the entity that pools money to purchase Aethlon Medical's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Vanguard Group Inc | 2023-12-31 | 21.2 K | Bartlett & Co. Llc | 2023-12-31 | 26.0 | Geode Capital Management, Llc | 2023-12-31 | 20.3 K | Blackrock Inc | 2023-12-31 | 7.3 K | Group One Trading, Lp | 2023-12-31 | 1.3 K | Tower Research Capital Llc | 2023-12-31 | 1.1 K | Advisor Group Holdings, Inc. | 2023-12-31 | 299 | Wells Fargo & Co | 2023-12-31 | 230 | Cutler Group Lp | 2023-12-31 | 130 | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 89.0 | Ubs Group Ag | 2023-12-31 | 61.0 |
Aethlon Medical Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 5.8M | 303.5K | 7.3M | (2.5M) | (2.9M) | (2.8M) | |
| Free Cash Flow | (5.3M) | (6.8M) | (10.1M) | (11.4M) | (10.3M) | (9.8M) | |
| Other Non Cash Items | 31.3K | (2.5K) | 30.5K | (46.6M) | (41.9M) | (39.8M) | |
| Net Income | (6.4M) | (7.9M) | (10.4M) | (12.0M) | (10.8M) | (10.3M) | |
| End Period Cash Flow | 9.6M | 9.9M | 17.2M | 14.6M | 16.8M | 17.7M | |
| Depreciation | 26.4K | 39.9K | 123.7K | 240.9K | 216.8K | 165.4K | |
| Change To Inventory | (74.8K) | 8.5K | (104.7K) | 456.6K | 411.0K | 431.5K | |
| Change Receivables | (74.8K) | 74.8K | (206.7K) | 57.6K | 66.3K | 69.6K | |
| Change To Netincome | 1.2M | 772.1K | 776.4K | 1.2M | 1.1M | 1.6M | |
| Investments | (151.7K) | (59.9K) | (349.2K) | (943.1K) | (848.8K) | (806.4K) |
Aethlon Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aethlon Medical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aethlon Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aethlon stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.56 | |
β | Beta against NYSE Composite | -0.31 | |
σ | Overall volatility | 2.71 | |
Ir | Information ratio | -0.25 |
Aethlon Medical Volatility Alert
Aethlon Medical exhibits very low volatility with skewness of -0.65 and kurtosis of 0.78. Aethlon Medical is a potential penny stock. Although Aethlon Medical may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Aethlon Medical. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Aethlon instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Aethlon Medical Fundamentals Vs Peers
Comparing Aethlon Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aethlon Medical's direct or indirect competition across all of the common fundamentals between Aethlon Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aethlon Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aethlon Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Aethlon Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aethlon Medical to competition |
| Fundamentals | Aethlon Medical | Peer Average |
| Return On Equity | -0.98 | -0.31 |
| Return On Asset | -0.47 | -0.14 |
| Operating Margin | (20.47) % | (5.51) % |
| Current Valuation | (3.87 M) | 16.62 B |
| Shares Outstanding | 2.63 M | 571.82 M |
| Shares Owned By Insiders | 6.43 % | 10.09 % |
| Shares Owned By Institutions | 1.98 % | 39.21 % |
| Number Of Shares Shorted | 69.7 K | 4.71 M |
| Price To Earning | (1.14) X | 28.72 X |
| Price To Book | 0.52 X | 9.51 X |
| Price To Sales | 6.91 X | 11.42 X |
| Revenue | 574.25 K | 9.43 B |
| Gross Profit | 574.25 K | 27.38 B |
| EBITDA | (11.76 M) | 3.9 B |
| Net Income | (12.03 M) | 570.98 M |
| Cash And Equivalents | 14.92 M | 2.7 B |
| Cash Per Share | 0.65 X | 5.01 X |
| Total Debt | 1.21 M | 5.32 B |
| Debt To Equity | 0.05 % | 48.70 % |
| Current Ratio | 9.66 X | 2.16 X |
| Book Value Per Share | 2.93 X | 1.93 K |
| Cash Flow From Operations | (10.51 M) | 971.22 M |
| Short Ratio | 8.70 X | 4.00 X |
| Earnings Per Share | (5.01) X | 3.12 X |
| Target Price | 25.0 | |
| Number Of Employees | 15 | 18.84 K |
| Beta | 1.97 | -0.15 |
| Market Capitalization | 3.1 M | 19.03 B |
| Total Asset | 17.51 M | 29.47 B |
| Retained Earnings | (142.36 M) | 9.33 B |
| Working Capital | 13.59 M | 1.48 B |
| Current Asset | 817 K | 9.34 B |
| Current Liabilities | 1.08 M | 7.9 B |
Note: Acquisition by Gikakis Nicolas of 32894 shares of Aethlon Medical at 1.52 subject to Rule 16b-3 [view details]
Aethlon Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aethlon . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Aethlon Medical Buy or Sell Advice
When is the right time to buy or sell Aethlon Medical? Buying financial instruments such as Aethlon Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 852.6K | 588.6K | 676.9K | 643.0K | Total Assets | 19.4M | 17.5M | 20.1M | 21.1M |
Use Investing Ideas to Build Portfolios
In addition to having Aethlon Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Books Thematic Idea Now
Books
Companies involved in publishing of books, newspapers, periodicals and other mass publications. The Books theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Books Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Aethlon Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Aethlon Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.01) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.47) | Return On Equity (0.98) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.